STAAR Surgical Company (STAA) - Total Liabilities
Based on the latest financial reports, STAAR Surgical Company (STAA) has total liabilities worth $117.44 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore STAA net asset momentum to track the company's year-over-year net asset growth rate.
STAAR Surgical Company - Total Liabilities Trend (1988–2025)
This chart illustrates how STAAR Surgical Company's total liabilities have evolved over time, based on quarterly financial data. See STAA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
STAAR Surgical Company Competitors by Total Liabilities
The table below lists competitors of STAAR Surgical Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hefei Jianghang Aircraft Equipment Corporation Ltd
SHG:688586
|
China | CN¥1.14 Billion |
|
H&K AG
PA:MLHK
|
France | €347.80 Million |
|
Ficont Industry (Beijing) Co. Ltd.
SHG:605305
|
China | CN¥664.38 Million |
|
Guangzhou Ruoyuchen Information Tec
SHE:003010
|
China | CN¥1.40 Billion |
|
Altus Group Limited
TO:AIF
|
Canada | CA$654.11 Million |
|
Bank Islam Malaysia Bhd
KLSE:5258
|
Malaysia | RM94.68 Billion |
|
Fushun Special Steel Co Ltd
SHG:600399
|
China | CN¥6.96 Billion |
|
NANOBIOTIX S.A. SP.ADR
F:5NRA
|
Germany | €152.24 Million |
Liability Composition Analysis (1988–2025)
This chart breaks down STAAR Surgical Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is STAAR Surgical Company worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how STAAR Surgical Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for STAAR Surgical Company (1988–2025)
The table below shows the annual total liabilities of STAAR Surgical Company from 1988 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $117.44 Million | +4.68% |
| 2024-12-31 | $112.19 Million | +9.20% |
| 2023-12-31 | $102.74 Million | +24.22% |
| 2022-12-31 | $82.71 Million | -5.18% |
| 2021-12-31 | $87.22 Million | +44.90% |
| 2020-12-31 | $60.19 Million | +26.35% |
| 2019-12-31 | $47.64 Million | +36.45% |
| 2018-12-31 | $34.91 Million | +39.67% |
| 2017-12-31 | $25.00 Million | -9.23% |
| 2016-12-31 | $27.54 Million | +14.23% |
| 2015-12-31 | $24.11 Million | +10.53% |
| 2014-12-31 | $21.81 Million | -5.49% |
| 2013-12-31 | $23.08 Million | +0.27% |
| 2012-12-31 | $23.02 Million | +17.75% |
| 2011-12-31 | $19.55 Million | +7.66% |
| 2010-12-31 | $18.16 Million | -51.72% |
| 2009-12-31 | $37.61 Million | +2.89% |
| 2008-12-31 | $36.55 Million | +103.60% |
| 2007-12-31 | $17.95 Million | +12.14% |
| 2006-12-31 | $16.01 Million | +29.23% |
| 2005-12-31 | $12.39 Million | -12.20% |
| 2004-12-31 | $14.11 Million | +19.63% |
| 2003-12-31 | $11.80 Million | -19.03% |
| 2002-12-31 | $14.57 Million | -23.23% |
| 2001-12-31 | $18.98 Million | -11.67% |
| 2000-12-31 | $21.48 Million | -33.07% |
| 1999-12-31 | $32.10 Million | +29.96% |
| 1998-12-31 | $24.70 Million | +40.34% |
| 1997-12-31 | $17.60 Million | +21.38% |
| 1996-12-31 | $14.50 Million | +43.56% |
| 1995-12-31 | $10.10 Million | +46.38% |
| 1994-12-31 | $6.90 Million | +1.47% |
| 1993-12-31 | $6.80 Million | +23.64% |
| 1992-12-31 | $5.50 Million | +7.84% |
| 1991-12-31 | $5.10 Million | -51.43% |
| 1990-12-31 | $10.50 Million | -50.70% |
| 1989-12-31 | $21.30 Million | +5.97% |
| 1988-12-31 | $20.10 Million | -- |
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorde… Read more